KDx Diagnostics Inc. announces issuance of patents covering URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States and Europe

SAN JOSE, Calif., Oct. 5, 2023 /PRNewswire/ — KDx Diagnostics Inc., a leading innovator in non-invasive bladder cancer tests, is pleased to announce the issuance of important patents in the US, EU, and South Korea relating to their joint work in developing new tests to aid in the…